Quantum BioPharma Ltd. Adjustments For Increase Decrease In Trade Account Payable
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Increase Decrease In Trade Account Payable of $1.18 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable · last filed 2026-03-26
- Quantum BioPharma Ltd. adjustments for increase decrease in trade account payable for the quarter ending 2025-12-31 was -$214.34K, a 106.86% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for increase decrease in trade account payable for the quarter ending 2025-09-30 was $1.42M, a 22.33% increase year-over-year.
- Quantum BioPharma Ltd. adjustments for increase decrease in trade account payable for the quarter ending 2025-06-30 was $147.92K, a 85.66% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for increase decrease in trade account payable for the quarter ending 2025-03-31 was -$177.48K.
| Period end | Adjustments For Increase Decrease In Trade Account Payable 3 month | Adjustments For Increase Decrease In Trade Account Payable 6 month | Adjustments For Increase Decrease In Trade Account Payable 9 month | Adjustments For Increase Decrease In Trade Account Payable 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$214.34K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $1.21M derived: sum of 2 quarters · filed 2026-03-26 | $1.36M derived: sum of 3 quarters · filed 2026-03-26 | $1.18M 20-F · filed 2026-03-26 |
| 2025-09-30 | $1.42M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $1.57M derived: sum of 2 quarters · filed 2025-11-06 | $1.39M 6-K · filed 2025-11-06 | $4.52M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-06-30 | $147.92K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$29.55K 6-K · filed 2025-08-07 | $3.10M derived: sum of 3 quarters · filed 2026-03-26 | $4.26M derived: sum of 4 quarters · filed 2026-03-26 |
| 2025-03-31 | -$177.48K 6-K/A · filed 2025-06-16 | $2.95M derived: sum of 2 quarters · filed 2026-03-26 | $4.11M derived: sum of 3 quarters · filed 2026-03-26 | $5.14M derived: sum of 4 quarters · filed 2026-03-26 |
| 2024-12-31 | $3.13M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $4.29M derived: sum of 2 quarters · filed 2026-03-26 | $5.32M derived: sum of 3 quarters · filed 2026-03-26 | $4.27M 20-F · filed 2026-03-26 |
| 2024-09-30 | $1.16M derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | $2.19M derived: sum of 2 quarters · filed 2025-11-06 | $1.15M 6-K · filed 2025-11-06 | |
| 2024-06-30 | $1.03M derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$17.70K 6-K · filed 2025-08-07 | ||
| 2024-03-31 | -$1.05M 6-K/A · filed 2025-06-16 | |||
| 2023-12-31 | $2.05M 20-F · filed 2026-03-26 |